Latest Insider Transactions at Akero Therapeutics, Inc. (AKRO)
This section provides a real-time view of insider transactions for Akero Therapeutics, Inc. (AKRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akero Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akero Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.02%
|
$130,000
$26.84 P/Share
|
|
Jul 25
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,272
-17.84%
|
$601,344
$27.33 P/Share
|
|
Jul 25
2024
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,272
+25.8%
|
$155,904
$7.01 P/Share
|
|
Jul 24
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
139,083
-49.25%
|
$3,616,158
$26.95 P/Share
|
|
Jul 24
2024
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,083
+43.47%
|
$973,581
$7.01 P/Share
|
|
Jul 23
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.18%
|
$14,000
$28.01 P/Share
|
|
Jul 23
2024
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.17%
|
$3,500
$7.01 P/Share
|
|
Jul 16
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
34,811
-24.8%
|
$974,708
$28.05 P/Share
|
|
Jul 16
2024
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,803
+28.01%
|
$208,621
$7.01 P/Share
|
|
Jul 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.99%
|
$115,000
$23.4 P/Share
|
|
Jun 28
2024
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.42%
|
$20,216
$19.94 P/Share
|
|
Jun 28
2024
|
Andrew Cheng President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.18%
|
$20,216
$19.94 P/Share
|
|
Jun 28
2024
|
Patrick Lamy Senior VP, Commercial Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
221
+1.16%
|
$4,199
$19.94 P/Share
|
|
Jun 28
2024
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+1.38%
|
$20,216
$19.94 P/Share
|
|
Jun 28
2024
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,064
+0.58%
|
$20,216
$19.94 P/Share
|
|
Jun 11
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,825
-3.64%
|
$62,150
$22.64 P/Share
|
|
Jun 11
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,516
-0.99%
|
$55,352
$22.64 P/Share
|
|
Jun 11
2024
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,380
-1.3%
|
$52,360
$22.64 P/Share
|
|
Jun 11
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,831
-5.7%
|
$62,282
$22.64 P/Share
|
|
Jun 11
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
7,894
-1.34%
|
$173,668
$22.64 P/Share
|
|
Jun 11
2024
|
Patrick Lamy Senior VP, Commercial Strategy |
SELL
Open market or private sale
|
Direct |
569
-2.97%
|
$12,518
$22.64 P/Share
|
|
Jun 03
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.94%
|
$95,000
$19.29 P/Share
|
|
May 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.9%
|
$100,000
$20.15 P/Share
|
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
400
-0.15%
|
$10,000
$25.02 P/Share
|
|
Apr 01
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,600
-1.71%
|
$110,400
$24.33 P/Share
|
|
Mar 13
2024
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
651
-0.24%
|
$18,228
$28.33 P/Share
|
|
Mar 13
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,969
-0.33%
|
$55,132
$28.33 P/Share
|
|
Mar 13
2024
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
724
-1.44%
|
$20,272
$28.33 P/Share
|
|
Mar 13
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
723
-0.92%
|
$20,244
$28.33 P/Share
|
|
Mar 13
2024
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
619
-0.34%
|
$17,332
$28.33 P/Share
|
|
Mar 04
2024
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,646
-20.84%
|
$722,610
$35.49 P/Share
|
|
Mar 04
2024
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,646
+9.93%
|
$268,398
$13.73 P/Share
|
|
Mar 04
2024
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-1.96%
|
$2,475,000
$33.99 P/Share
|
|
Mar 04
2024
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+5.35%
|
$1,350,000
$18.55 P/Share
|
|
Mar 01
2024
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
83,321
+23.65%
|
$0
$0.62 P/Share
|
|
Jan 02
2024
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+6.34%
|
$0
$0.62 P/Share
|
|
Dec 27
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,414
-2.84%
|
$129,936
$24.0 P/Share
|
|
Dec 27
2023
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,414
+2.76%
|
$32,484
$6.36 P/Share
|
|
Dec 14
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
597
-0.76%
|
$11,940
$20.76 P/Share
|
|
Dec 14
2023
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
611
-1.2%
|
$12,220
$20.76 P/Share
|
|
Dec 14
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,628
-0.29%
|
$32,560
$20.76 P/Share
|
|
Dec 14
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
543
-0.29%
|
$10,860
$20.76 P/Share
|
|
Dec 14
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
514
-0.28%
|
$10,280
$20.76 P/Share
|
|
Dec 11
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
7,405
-1.32%
|
$148,100
$20.02 P/Share
|
|
Dec 11
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,405
+1.31%
|
$44,430
$6.36 P/Share
|
|
Dec 08
2023
|
Jonathan Young Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+14.9%
|
-
|
|
Dec 08
2023
|
William Richard White Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+38.94%
|
-
|
|
Dec 08
2023
|
Patrick Lamy Senior VP, Commercial Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
18,570
+50.0%
|
-
|
|
Dec 08
2023
|
Timothy Rolph Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+15.07%
|
-
|
|
Dec 08
2023
|
Catriona Yale Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,497
+29.28%
|
-
|